Related Experiment Video
Updated: May 16, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Targeting Hyperlipidemia: Investigating the Regulatory Roles of NPC1L1 and SREBP-2 and the Therapeutic Potential of
Suresh Kumar Dev1, Rajnish Srivastava2, Aruna Sharma2
1Venkateshwara Institute of Pharmacy, Sai Tirupati University, Udaipur, Rajasthan, India.
Introduction:
Hypercholesterolemia is the most common form of dyslipidemia and is strongly linked to cardiovascular disease. Over the past three decades, the global burden of dyslipidemias has shown a steady rise.
Methods:
A comprehensive literature review was conducted to synthesize current evidence on the relationship between role of phytomedicine in hyperlipidemia with respect to reduction of cholesterol uptake, amelioration of cholesterol esterification, suppression of cholesterol synthesis, acceleration of cholesterol excretion in the liver, focusing on the mechanism and efficacy of plant- based bioactives published between 2000 and 2025. Literature was retrieved through computerized searches in Google Scholar and PubMed using specific keywords such as "Herbs, Medicinal plants, Bioactives, Dyslipidemia, Hyperlipidemia, lipid metabolism, NPC1L1, SREBP-2", clinical trial, and traditional medicine. Studies were included if they were peer-reviewed, published within the defined period, and provided direct insights for the regulatory roles of NPC1L1 and SREBP-2 in dyslipidemia and the therapeutic Potential of Bioactive Compounds.
Results:
The lipid-lowering effect of plant-based bioactives is significantly influenced by transcription factors such as LXR, SREBP, PPARα, and PPARγ. The molecules NPC1L1, HMGCR, PCSK9, and CYP7A1 play critical roles in these pathways.
Discussion:
To combat the progression of atherosclerosis, coronary heart disease, and metabolic syndrome, lipid-lowering agents have proven to be effective tools for prevention and treatment. However, the current options primarily consist of chemical drugs. In contrast, herbal medicine, with its extensive historical usage, offers an alternative approach that expands the range of treatment possibilities.
Conclusion:
Plant-based bioactives inhibit cholesterol absorption in intestine-lining cells, reduce cholesterol synthesis, improve reverse cholesterol transport, and aid liver cholesterol excretion.
Insights
Phytomedicines offer a natural approach to managing hyperlipidemia by inhibiting cholesterol absorption and synthesis. These plant-based compounds also enhance cholesterol excretion, providing an alternative to conventional drugs for cardiovascular health.
Area of Science:
- Pharmacology and Phytomedicine
- Cardiovascular Disease Research
- Lipid Metabolism
Background:
- Hypercholesterolemia, a prevalent form of dyslipidemia, significantly contributes to cardiovascular disease.
- The global incidence of dyslipidemias has steadily increased over the last three decades.
Purpose of the Study:
- To review the scientific evidence on the role of phytomedicine in managing hyperlipidemia.
- To synthesize information on plant-based bioactives affecting cholesterol metabolism, focusing on mechanisms and efficacy.
Main Methods:
- A comprehensive literature review was conducted using Google Scholar and PubMed.
- Keywords included "Herbs, Medicinal plants, Bioactives, Dyslipidemia, Hyperlipidemia, lipid metabolism, NPC1L1, SREBP-2."
- Studies published between 2000 and 2025, focusing on regulatory roles of NPC1L1 and SREBP-2, were included.
Main Results:
- Plant-based bioactives modulate lipid levels through transcription factors like LXR, SREBP, PPARα, and PPARγ.
- Key molecules in these pathways include NPC1L1, HMGCR, PCSK9, and CYP7A1, influencing cholesterol homeostasis.
- Bioactives affect cholesterol uptake, esterification, synthesis, and excretion.
Conclusions:
- Lipid-lowering agents are crucial for preventing atherosclerosis, coronary heart disease, and metabolic syndrome.
- Herbal medicine presents a viable alternative or complementary approach to synthetic drugs for hyperlipidemia treatment.
- Plant-derived compounds effectively inhibit intestinal cholesterol absorption, reduce hepatic cholesterol synthesis, and promote cholesterol excretion.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Pharmacogenomics: Identification of New Drug Targets
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Nuclear Protein Sorting
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
